GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets
C. Rifampicin + Isoniazid Tablets
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated Tablet contains:
Rifampicin USP………………………………..…300mg
Isoniazid IP……………………………………..75mg
Pyrazinamide IP………………………………400mg
Ethambutol Hydrochloride IP………….275mg
Excipients……………………………............q.s
Colour: Sunset Yellow FCF
B. Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets
Each film coated Tablet contains:
Rifampicin IP………………………………..…150mg
Isoniazid IP……………………………………..75mg
Ethambutol Hydrochloride IP………….275mg
Excipients………………………………………q.s
Colour: Sunset Yellow FCF
c. Rifampicin + Isoniazid Tablets
Each film coated Tablet contains:
Rifampicin USP………………………………..…300mg
Isoniazid BP……………………………………..150mg
Excipients……………………………............q.s
Colour: Red Oxide of Iron & Titanium Dioxide USP
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
WARNING: It is dangerous to take this preparation except in accordance with the medical advice. Not to be sold by retail without the prescription of registered Medical Practitioner.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by physician.
Rifampicin + Isoniazid + Pyrazinamide + Ethambutol Hydrochloride Tablets 150mg+75mg+400mg+275mg Technical specification:
| Product Name: | Rifampicin + Isoniazid + Pyrazinamide + Ethambutol Hydrochloride Tablets |
| Brand Name: | FUNFUNATI |
| Strength: | 150mg+75mg+400mg+275mg , 150mg+75mg+275mg , 300mg+150mg |
| Dosage Form: | Tablet (film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 strips of 10 Tablets each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Anti-tuberculosis |
| Indication: | This combination is used in the treatment of tuberculosis. |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Rifampicin + Isoniazid + Pyrazinamide + Ethambutol Hydrochloride Tablets
- Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets
- Rifampicin + Isoniazid Tablets
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Rifampicin + Isoniazid + Pyrazinamide + Ethambutol Hydrochloride Tablets
Each film coated Tablet contains:
Rifampicin IP………………………………..…150mg
Isoniazid IP……………………………………..75mg
Pyrazinamide IP………………………………400mg
Ethambutol Hydrochloride IP………….275mg
Excipients………………………………………q.s
Colour: Sunset Yellow FCF - Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets
Each film coated Tablet contains:
Rifampicin IP………………………………..…150mg
Isoniazid IP……………………………………..75mg
Ethambutol Hydrochloride IP………….275mg
Excipients………………………………………q.s
Colour: Sunset Yellow FCF - Rifampicin + Isoniazid Tablets
Each film coated Tablet contains:
Rifampicin USP………………………………..…300mg
Isoniazid BP……………………………………..150mg
Excipients………………………………………q.s
Colour: Red Oxide of Iron & Titanium Dioxide USP
THERAPEUTIC INDICATIONS:
- This combination is used in the treatment of tuberculosis. rifampicin works by inactivating a bacterial enzyme (rna-polymerase) which is required by tb bacteria to make essential proteins and to reproduce, while isoniazid prevents these bacteria from forming their own protective covering. together, they kill the bacteria and eradicate the infection. ethambutol, on the other hand works by slowing the growth of these bacteria.
CAUTION & WARNING:
- CAUTION: Read enclosed leaflet before use. Keep medicine out of reach of children. tablets to be swallowed as a whole, and not to be chewed or crushed.
- WARNING: It is dangerous to take this preparation except in accordance with the medical advice. Not to be sold by retail without the prescription of registered Medical Practitioner.
STORAGE & DOSAGE:
- Storage: Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture.
- Dosage: As directed by physician.
Introduction to Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets 150mg+75mg+275mg
Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets 150mg+75mg+275mg is a highly effective fixed-dose combination medicine widely prescribed for the treatment of Tuberculosis (TB). This formulation combines three powerful anti-tuberculosis drugs: Rifampicin, Isoniazid, and Ethambutol to eliminate TB-causing bacteria and prevent multidrug resistance.
Taj Medico Ltd is a trusted and well-established Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets 150mg+75mg+275mg Manufacturer in India, delivering high-quality pharmaceutical products to domestic and international healthcare markets. Located in Vapi, Taj Medico provides world-class manufacturing solutions for hospitals, government procurement agencies, pharmaceutical distributors, NGOs, and wholesalers worldwide.
The demand for anti-TB medicines continues to rise globally due to increasing tuberculosis cases in developing nations such as Nigeria, Kenya, South Africa, Philippines, Indonesia, and several Latin American countries.
How Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets Works
This triple-drug formulation works through multiple mechanisms:
Rifampicin
Blocks bacterial RNA polymerase, stopping protein production needed for bacterial growth.
Isoniazid
Prevents bacteria from forming protective cell walls.
Ethambutol
Inhibits bacterial cell wall synthesis and prevents bacterial multiplication.
Together, these medications kill tuberculosis bacteria and help eliminate infection effectively.
Doctors commonly prescribe this medicine for:
- Pulmonary tuberculosis
- Extrapulmonary tuberculosis
- Intensive phase TB treatment
- National tuberculosis control programs
- Hospital treatment protocols
Patients should always complete the full course even if symptoms improve.
Side Effects of Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets
Taj Medico Ltd ensures strict quality manufacturing standards, but some patients may experience:
- Low blood platelets
- Peripheral neuropathy
- Nausea
- Vomiting
- Abdominal pain
- Skin rash
- Itching
- Hepatitis
- Dizziness
- Lethargy
- Visual disturbances
Patients should contact healthcare providers immediately if they experience:
- Yellowing of skin
- Yellow eyes
- Dark urine
- Severe abdominal pain
- Vision problems
Doctors may monitor liver function regularly during treatment.
Why Taj Medico is the Leading Manufacturer in India
Taj Medico Ltd has built a strong reputation as a leading:
- Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets PAN India Manufacturer
- Manufacturer Supplier and PCD Pharma Franchise provider
- Manufacturer from Mumbai
- Manufacturer in Vapi
- Global pharmaceutical exporter
The company delivers consistent quality, affordable pricing, and reliable global distribution.
Regulatory Documentation for Global Buyers
International pharmaceutical importers require complete compliance documentation, and Taj Medico Ltd provides:
WHO-GMP Certification
Ensures global manufacturing compliance.
EU-GMP Certification
Supports regulated market exports.
COPP Certificate
Required for product registration in many countries.
CTD Dossier
Helps importers register products in their respective countries.
Additional Documentation
- Certificate of Analysis
- Stability Data
- Free Sale Certificate
- Product Specifications
- Batch Manufacturing Records
- MSDS Reports
Custom Packaging and Labeling Services
Taj Medico Ltd offers flexible packaging options:
- Alu-Alu packaging
- Blister packs
- Strip packaging
- Bottle packaging
- Hospital bulk packaging
Custom labeling services include:
- Private branding
- Multilingual packaging
- Country-specific labeling compliance
- Distributor branding support
Shelf Life, Storage & Dosage Form
Dosage Form
Tablet
Strength
Shelf Life
24–36 months
Storage
Store below 25°C in a cool, dry place away from sunlight.
Global Export Certifications
Taj Medico Ltd offers products supported by:
- WHO-GMP
- EU-GMP
- COPP
- CTD Dossier
- ISO Certifications
- Product Registration Assistance
These certifications make Taj Medico a preferred Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets export from India partner.
Top 20 Export Countries
- United States
- United Kingdom
- South Africa
- Nigeria
- Kenya
- Ghana
- Ethiopia
- Philippines
- Vietnam
- Thailand
- Sri Lanka
- Myanmar
- Peru
- Chile
- Argentina
- Brazil
- United Arab Emirates
- Saudi Arabia
- Yemen
- Uzbekistan
Technical Product Specification Table
| Parameter | Details |
|---|---|
| Product Name | Rifampicin + Isoniazid + Ethambutol Hydrochloride Tablets |
| Strength | 150mg + 75mg + 275mg |
| Dosage Form | Tablet |
| Category | Anti-Tuberculosis Medicine |
| Packaging | Blister/Alu-Alu/Bottle |
| Shelf Life | 24–36 Months |
| Storage | Below 25°C |
| Certifications | WHO-GMP, EU-GMP, COPP |
| MOQ | As Per Buyer Requirement |
| Export Markets | Worldwide |
Why Global Buyers Choose Taj Medico
State-of-the-Art Manufacturing
Advanced production facilities in Vapi.
Affordable Pricing
Competitive bulk pricing for global buyers.
Quality Assurance
Strict batch testing and quality inspections.
Global Supply Chain Support
Reliable worldwide logistics support.
Third-Party Manufacturing
Private label and contract manufacturing options available.
Top 20 FAQs
1. What is this medicine used for?
Treatment of tuberculosis.
2. Is bulk export available?
Yes.
3. Is private labeling available?
Yes.
4. What certifications are provided?
WHO-GMP, EU-GMP, COPP.
5. What is shelf life?
24–36 months.
6. Is hospital supply available?
Yes.
7. Is PCD franchise available?
Yes.
8. Can NGOs order?
Yes.
9. Is product registration support available?
Yes.
10. What packaging is available?
Blister, bottle, strips.
11. What is MOQ?
Buyer dependent.
12. Can governments procure directly?
Yes.
13. Is export documentation included?
Yes.
14. Is third-party manufacturing available?
Yes.
15. Is multilingual packaging offered?
Yes.
16. How should it be stored?
Below 25°C.
17. Is it prescription-based?
Yes.
18. Does Taj Medico export globally?
Yes.
19. Why choose Taj Medico?
Quality and affordability.
20. How to place an order?
Contact Taj Medico directly.






